# InExoplat Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inexoplat-co

- Industry: Biotechnology
- Headquarters: Pohang, South Korea
- Website: www.inexoplat.com/
- Total disclosed funding: $2.3M
- Latest round: Series A (Dec 7, 2023)
- Investors on record: 1

## About

Founded in 2021 and based in Incheon, South Korea, InExoplat Co., Ltd., operates as a biopharmaceutical company that develops exosome-based drugs that are being used in the procedure of stem cell therapies. In December 2023, INEXOPLAT raised KRW 3 billion in series A funding from Vine Ventures. As of 2023, the company is led by its CEO, Sunghwan Kim.

Inexoplat offers science and drug development solutions that include developing anticancer agents that expand their application to solid tumors.

The company utilizes exosomes, extracellular vesicles secreted by cells, for drug delivery of anticancer drugs. This technology aims to protect drugs, ensure stability, and enhance.

## Funding rounds

- Series A, Dec 7, 2023, $2.3M — Vine Ventures

## Investors

- Vine Ventures — Series A